Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
about
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary studyXPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma riskPolymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in TaiwanFunctional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assaysGenetic susceptibility to lung cancer--light at the end of the tunnel?Human AP endonuclease 1: a potential marker for the prediction of environmental carcinogenesis riskJapanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patientsSingle nucleotide polymorphisms in DNA repair genes and prostate cancer riskNucleotide excision repair gene polymorphisms, meat intake and colon cancer riskGenetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican womenGene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancerAssociation between XPD (Lys751G1n) Polymorphism and Lung Cancer Risk: A Population-Based Study in IranPolymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New HampshireGenome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancerGenetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.SNP-SNP interactions in breast cancer susceptibility.Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario.Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern SpainModified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP.Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking femalesThe effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysisPterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.Breast Cancer and DNA Repair Capacity: Association With Use of Multivitamin and Calcium Supplements.Relationship between XPD Lys 751 Gln polymorphism and colorectal cancer risk: a case-control study in a population-based studyImpact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis.Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapyPolymorphisms in the DNA repair gene ERCC2/XPD and breast cancer risk: a HapMap-based case-control study among Han Women in a Chinese less-developed areaBladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.The association of DNA Repair with breast cancer risk in women. A comparative observational studyGains of ubiquitylation sites in highly conserved proteins in the human lineage.Women with endometriosis have a higher DNA repair capacity and diminished breast cancer riskDNA Repair Gene Polymorphisms in the Nucleotide Excision Repair Pathway and Lung Cancer Risk: A Meta-analysis.
P2860
Q21260394-8CD37444-82BF-4C59-B634-5A2343F980CAQ23909400-960B3EB5-16FD-42BD-926E-DA7C5F5AF503Q24805138-F76FEFCE-F61B-4240-8AF1-F77A86905A80Q24816878-1BDA86AE-EA36-4B6D-9310-305D5205D96EQ26852320-ACF01BB3-E866-4B02-9BC3-938D6EB6211BQ26863138-FF896B8D-DD9B-41DD-832E-60249B89BD7BQ27851471-26B1FD55-8617-4626-AF8D-CE08FE4C1BEAQ28382908-8C0178A2-FB4C-4933-9E53-208DA24990FFQ28383002-ACE7B2B6-B0DF-4C91-B5F5-FE3092BEBAE0Q28387797-B924091B-E620-4C3D-89EB-A74AABD3FE23Q28390577-4D3550C9-3100-40B3-A3CB-0E8CB9565381Q28392548-8E0CED95-6FB7-4CCD-B32A-646EC64101DFQ28396316-A9486EA1-F426-466D-BFF4-A8ADFEBC66A3Q28396452-A70BA380-F5FB-4B5B-A689-44AF3730D451Q28943482-3EB40BA8-AF9C-42A1-A78C-29A6D6C40A44Q30829689-9E06484E-5FCF-46F6-B7C8-428C2A607FDDQ30887499-FE150954-2FB2-4F44-B609-CB6D89934F70Q31080865-F8F93261-C847-47ED-B218-340736F33DE4Q33242109-D45C6A0B-01F9-4EF4-AD54-549323F96E38Q33293469-6C83AEE2-CD16-41A9-8BDE-28D30C626280Q33294473-6FFFB1F9-9274-49E0-9571-EDF986451941Q33337970-210DCB00-BA24-489D-BE0F-76CB0069228DQ33347615-26894347-579B-40D2-88AE-BE145DF56A1BQ33415904-AFD84D81-71BE-4B25-A319-F7FFC1EDC12DQ33555896-AD256648-20A7-46A7-9932-CD1B2557EDC7Q33560417-F2DC0689-E795-462B-B474-03F6FDD60635Q33568590-743A7A34-C00D-4FDB-905B-51E6AF611D4AQ33575548-A94E0796-7472-4125-B9C4-B00DEC46E199Q33596523-C68AA939-EF11-493E-9BAC-154ECD8517A3Q33618495-B4666BEF-50AC-40CA-89B7-06B1DB66E10CQ33648490-02E94835-F6CA-47B5-877D-00C4E5C7936EQ33730235-713E8C0D-F10C-4939-90E6-EA4CDDC3BA9FQ33985880-8753335F-DF93-4D86-A3C9-48AA11D0F7C7Q34013081-B9F1066E-81BA-44F3-B0C6-8FE2AC98DF32Q34284010-83203FCA-1105-4D3C-B4E9-8438DB32541DQ34399048-AD7C1DAC-F710-46E2-AF49-A9FE151B0634Q34454257-E0B4C633-8632-4409-9A76-76644B188104Q34479638-F694D01A-F321-419E-B4D0-7EE943930AACQ34590328-DA3DC5AD-CCDA-4A24-9EDB-510284ED5404Q34617926-E90F62E8-67BD-4892-B4A1-F1B974DC4BDD
P2860
Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@ast
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@en
type
label
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@ast
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@en
prefLabel
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@ast
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@en
P2093
P1433
P1476
Modulation of nucleotide excis ...... hisms in lung cancer patients.
@en
P2093
Mohrenweiser H
P304
P407
P577
2001-02-01T00:00:00Z